Skip to main content

Peer Review reports

From: Design and synthesis of new 1,2,3-triazole-methoxyphenyl-1,3,4-oxadiazole derivatives: selective butyrylcholinesterase inhibitors against Alzheimer’s disease

Original Submission
5 Dec 2024 Submitted Original manuscript
19 Dec 2024 Reviewed Reviewer Report
22 Dec 2024 Reviewed Reviewer Report
26 Dec 2024 Reviewed Reviewer Report
2 Feb 2025 Author responded Author comments - Mina Saeedi
10 Feb 2025 Reviewed Reviewer Report
11 Feb 2025 Reviewed Reviewer Report
7 Mar 2025 Author responded Author comments - Mina Saeedi
Resubmission - Version 2
2 Feb 2025 Submitted Manuscript version 2
19 Mar 2025 Reviewed Reviewer Report
21 Mar 2025 Author responded Author comments - Mina Saeedi
Resubmission - Version 3
21 Mar 2025 Submitted Manuscript version 3
26 Mar 2025 Author responded Author comments - Mina Saeedi
Resubmission - Version 4
26 Mar 2025 Submitted Manuscript version 4
4 Apr 2025 Author responded Author comments - Mina Saeedi
Resubmission - Version 5
4 Apr 2025 Submitted Manuscript version 5
Publishing
4 Apr 2025 Editorially accepted
15 Apr 2025 Article published 10.1186/s13065-025-01475-5

You can find further information about peer review here.

Back to article page